SOUTH SAN FRANCISCO, Calif. — Thermo Fisher Scientific today introduces two next-generation sequencing (NGS) systems designed to deliver a comprehensive solution that simplifies targeted sequencing. Built upon the proven capabilities of Ion Torrent technology, the new Ion S5 and Ion S5 XL benchtop systems provide scientists with rapid, cost-effective and flexible platforms that can be […]
Woburn, MA — truXTRAC is a comprehensive novel solution for clinical-grade DNA extraction from Formalin-Fixed, Paraffin-Embedded (FFPE) tissues utilizing Covaris Adaptive Focused Acoustics® (AFA™) technology. The unique focused, short-wavelength acoustic field generated by AFA enables rapid, active paraffin removal and rehydration of FFPE tissue samples in aqueous buffer, thus enabling efficient and rapid tissue digestion, […]
BOULDER, Colo.– ArcherDX expands the application of its Anchored Multiplex PCR (AMP™) technology to include DNA variant detection with the Archer™ VariantPlex™ p53 Panel. The panel is a targeted next-generation sequencing (NGS)-based assay to detect germline and somatic mutations of the TP53 gene, which is frequently mutated in cancer. “With complete exon coverage of TP53, […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced it has completed the acquisition of GenoLogics Life Science Software Inc., a developer of industry leading laboratory information management systems (LIMS) for life sciences organizations. “We look forward to working with the talented team at GenoLogics and to further integrate their life science software as part […]
Shirley, New York – The constant-upgrading platform of genome sequencing is to meet the demand of the development of all kinds of Human genome research. For providing the best service to its costumers, CD Genomics recently introduced the HiSeq X Ten System for its human whole genome sequencing service. This platform is from Illumina, and […]
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a non- exclusive distribution agreement for the commercialization of SYGNIS’ proprietary product portfolio in Australia with GeneWorks Pty Ltd. Under the terms of the agreement, SYGNIS has granted GeneWorks the rights to promote, market and […]
FRANKLIN LAKES, N.J. — BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it has completed the acquisition of Cellular Research, Inc. BD is a global leader in characterizing and isolating single cells for analysis, with more than 30 years of experience in developing […]
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that Molecular Diagnostics Laboratories (MDL) has standardized on its leading bioinformatics software platform in order to rapidly launch its BRCA1/2 genomic testing program. MDL, based in Covington, KY, will utilize the PierianDx Clinical Genomicist Workstation™ 3.0 to jump-start its BRCA testing program. […]
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a non- exclusive distribution agreement for the commercialization of SYGNIS’ proprietary product portfolio in Australia with GeneWorks Pty Ltd. Under the terms of the agreement, SYGNIS has granted GeneWorks the rights to promote, market and […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced commercial availability of a new high throughput single-cell mRNA sequencing workflow for its C1TM system to enable large-scale studies to characterize heterogeneous samples. This validated workflow includes a new advanced integrated fluidic circuit (IFC) and reagent kit that significantly increases throughput and ease-of-use, while simultaneously […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
